Triage Survey for Neurology Research Eligibility

Last updated: October 23, 2023
Sponsor: Adams Clinical
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Optional Medication Washout

Survey

Clinical Study ID

NCT06104852
TRIAGE-Neuro-101
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Participant and study partner (when applicable) have signed an ICF prior tostudy-specific procedures being performed.
  • Participant and study partner (when applicable) are at least 18 years old.

Exclusion

Exclusion Criteria:

  • Participant lacks the language skills or cognitive ability to understand the screeningprocess.
  • Participant is pregnant, breast-feeding, or planning to become pregnant.
  • History of a clinically significant illness which in the investigator's opinion mayimpact participant safety or the ability to analyze study results.
  • Participant represents an acute suicidal risk, as defined as a "yes" response toideation on Columbia-Suicide Severity Rating Scale questions 4 or 5, or answer "yes"to behavior questions within 90 days of screening.
  • Moderate or severe substance use disorder within 90 days prior to screening, accordingto DSM-5 criteria that in the investigator's opinion could pose undue risk to theparticipant.
  • Any condition that in the investigator's opinion makes a participant unsuitable forthe study.
  • Currently employed by Adams Clinical or a first-degree relative of an employee workingon this study.

Study Design

Total Participants: 600
Treatment Group(s): 2
Primary Treatment: Optional Medication Washout
Phase:
Study Start date:
June 02, 2023
Estimated Completion Date:
June 02, 2027

Study Description

TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials. Secondary objectives include identifying participant characteristics among the clinical trial-seeking population, identifying the percentage of potential participants currently taking prescribed memory medications that could exclude them from clinical trial participation, examining how changes in prescription memory medications impact performance on cognitive assessments, and identifying the percentage of potential participants whose laboratory results could exclude them from clinical trial participation.

Connect with a study center

  • Copley Clinical

    Boston, Massachusetts 02116
    United States

    Site Not Available

  • Adams Clinical

    Watertown, Massachusetts 02472
    United States

    Active - Recruiting

  • Berman Clinical

    New York, New York 10029
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.